China Adds AstraZeneca’s Breast Cancer Drug Enhertu to State Health Coverage
SHANGHAI – AstraZeneca’s (NASDAQ: AZN) blockbuster breast cancer drug Enhertu will be added to China’s state-run health insurance scheme from […]
China Adds AstraZeneca’s Breast Cancer Drug Enhertu to State Health Coverage Read More »